Stock Information
Relay Therapeutics Inc (RLAY)
Ticker Symbol: RLAY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,296.63 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.565
Revenue (TTM): $0.06 M
Dividend Yield: N/A%
ROE: -43.94%
Latest News
-
Guggenheim Maintains Buy on Relay Therapeutics, Raises Price Target to $26
Tue, May 26, 2026 8:52 AM
-
HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Raises Price Target to $28
Tue, May 26, 2026 6:48 AM
-
Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular Anomalies - Slideshow
Fri, May 22, 2026 7:25 PM
-
Advance Auto Parts Posts Upbeat Q1 Earnings, Joins IBM, Ralph Lauren And Other Big Stocks Moving Higher On Thursday
Thu, May 21, 2026 10:31 AM
-
Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade)
Thu, May 21, 2026 7:32 AM
Key Financials
Financial data not available
